Terns Pharmaceuticals, Inc.
TERN
$2.92
-$0.13-4.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.68% | 35.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.05% | -2.34% | |||
| Operating Income | -4.05% | 2.34% | |||
| Income Before Tax | 0.57% | 3.49% | |||
| Income Tax Expenses | -35.48% | 1.64% | |||
| Earnings from Continuing Operations | 0.67% | 3.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.67% | 3.48% | |||
| EBIT | -4.05% | 2.34% | |||
| EBITDA | -4.13% | 2.33% | |||
| EPS Basic | 15.28% | 7.63% | |||
| Normalized Basic EPS | 15.24% | 7.62% | |||
| EPS Diluted | 15.28% | 7.63% | |||
| Normalized Diluted EPS | 15.24% | 7.62% | |||
| Average Basic Shares Outstanding | 17.25% | 4.51% | |||
| Average Diluted Shares Outstanding | 17.25% | 4.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||